Critical Diagnostics Release: Presage® ST2 Assay Enters Routine Use for Heart Failure Patient Care

Published: Jan 03, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that a major European medical center, Hospital Germans Trias i Pujol in Barcelona Spain, is now using the company’s Presage® ST2 Assay for routine care and management of their heart failure patients.

Back to news